Lobbying

Global Life Technologies's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $40K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.

Global Life Technologies

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$40K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Global Life Technologies lobbying by quarter
Global Life Technologies lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$15K1
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$10K1
Q2 2025$10K1
Q3 2025$10K1
Q4 2025$10K1
Q1 2026$10K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Health issues$38.3K · 15 reports
  • Budget and appropriations$38.3K · 14 reports
  • Defense$38.3K · 14 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Disease Control & Prevention (CDC)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
Cura Strategies$115K15 quarters

Former officials lobbying for it

Former position
EMILY CROUCHAide to Sens. James Inhofe, Thom Tillis, John BoozmanQ2 2026
SCOTT C LEEZERAide to Sen. Dick DurbinQ2 2026
MICHAEL LISOWSKIAide to Rep. Joe HeckQ4 2023

Lobbying reports

Filed by
07/20for Q2Cura Strategies$20K
05/09for Q1Cura Strategies$10K
01/20for Q4 2025Cura Strategies$10K
25/10/20for Q3 2025Cura Strategies$10K
25/07/22for Q2 2025Cura Strategies$10K
25/04/21for Q1 2025Cura Strategies$10K
25/01/21for Q4 2024Cura Strategies$10K
24/10/09for Q3 2024Cura Strategies$10K
24/07/30for Q2 2024Cura Strategies$10K
24/06/03for Q1 2024Cura StrategiesUnder $5,000
24/01/30for Q4 2023Cura StrategiesUnder $5,000
23/11/07for Q3 2023Cura StrategiesUnder $5,000
23/07/20for Q2 2023Cura StrategiesUnder $5,000
23/05/05for Q1 2023Cura Strategies$15K
23/01/19for Q4 2022Cura StrategiesUnder $5,000